washingtonexaminer.com / .washingtonexaminer-com-healthcare / Page 5

Nine midsize pharmaceutical companies signed on to most-favored-nation deals with President Donald Trump, lowering drug prices for U.S. consumers.

The White House has not detailed what Trump will announce, but the event comes as the administration focuses on lowering healthcare costs.

Gov. Josh Shapiro's (D-PA) handling of the measles outbreak and spat with HHS Secretary RFK Jr. could make or break his 2028 chances.

The Walmart lawsuit was one of the DOJ's most significant civil actions targeting a company over its alleged role in the opioid crisis.

AFIT has ads targeted to Sen. Roger Marshall (R-KS), Jon Husted (R-OH), and Susan Collins (R-ME) supporting industry-friendly food reforms.

A Maryland office received $622,883 to help youth escape drug and mental health problems but hardly served any clients, a DOJ report found.

The Washington Examiner's Gabrielle Etzel emphasized healthcare affordability ahead of the midterm elections and said Trump is making a dent in prices.

The approvals come as COVID-19 infections increased in most states this month.

Kennedy's visit to the Pacific island nation became a point of controversy during his confirmation process last year.

A Senate GOP investigation into abortion pill makers revealed pharmaceutical companies likely aren't following safety protocols.